MONOCLONAL CD138 (EP201)

MONOCLONAL CD138 (EP201)

General description

CD138, Syndecan 1, is expressed in the late stages of B-cell differentiation with progression towards plasma cells.1,2 It can be used to differentiate lymphoplasmacytic lymphoma from marginal zone lymphoma.1 ALK+ large B-cell lyphoma (LBCL) usually strongly expresses CD138 whereas lineage-associated markers such as anti-CD20 and anti-CD79a do not stain ALK+LBCL.3,7 Anti-CD138 is immunoreactive with HHV8-associated primary effusion lymphoma even though the lymphoma cells lack the expression of B-cell markers.5 Anti-CD138 is a good marker to identify and enumerate plasma cells, benign, reactive, or malignant, in bone marrow biopsy specimens.4,6 CD138 is also expressed in epithelial cells.6

Legal Information

Cell Marque is a trademark of Sigma-Aldrich Co. LLC

Linkage

CD138 Positive Control Slides, Product No. 138S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

Other Notes

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

Physical form

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and ﹤0.1% Sodium Azide.

Preparation Note

Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.

Quality

IVDIVDIVDRUO

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level Manufacturer Further Info Storage Temp. Form Price Quantity
3572848 MONOCLONAL CD138 (EP201) 100; 500 SIGMA-ALDRICH (For In Vitro Diagnostic Use in Select Regions (See Chart)) 2-8°C buffered aqueous solution
£546.10 (exc VAT) per EACH
-
+